Ketek Lawsuit Information

Ketek is an antibiotic used for the treatment of serious and drug resistant bacterial infections. Ketek was approved by the U.S. Food and Drug Administration (FDA) in April 2004 and is manufactured by Sanofi-Aventis.

What you should be aware of:

Since its approval in 2004, Ketek has proven controversial. In June 2006, the risk of liver damage was added to the label and in February 2007 the approved uses were reduced. The drug has undergone two FDA reviews and a senate investigation. Ketek is now approved only for community-acquired pneumonia in patients 18 years of age and older. Previously, the drug was also approved for the treatment of pneumonia, chronic bronchitis and sinusitis.

The FDA made the decision to limit the uses of Ketek because the benefits do not out weigh the risks. The label change in February 2007 also strengthened warnings for the risk of liver damage, loss of consciousness and visual disturbances. The warning includes that no one with myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily) should take Ketek.

Prior to the approval of Ketek, the FDA was aware of potential liver problems but believed they were similar to other marketed antibiotics. Yet in January 2006, Annals of Internal Medicine published an article reporting on three patients with serious liver toxicity. One patient recovered, one patient had to undergo a liver transplant and the third patient died as a result. When the livers of the latter two patients were examined in the laboratory, massive tissue death was found. All three patients were reported as not taking any other medications. The patients in the report were also only on the drug for a few days after symptoms of acute hepatitis occurred and all had jaundice and abnormal results on liver function tests. All three cases were reported to the FDA.

Contact us:

If you or a loved one has been injured due to the use of Ketek, you need a Ketek attorney familiar with new developments in the investigation of Ketek to help you make important personal and legal decisions, and if needed to file a lawsuit. Contact us now to get the help you deserve. Give us a call at 800-992-6878 or CLICK HERE for a free case evaluation.

Related Articles:

Questions and Answers on Ketek (telithromycin), Feb. 12, 2007 http://www.fda.gov/cder/drug/infopage/telithromycin/qa22007.htm

The RI Supreme Court licenses all lawyers in the general practice of law. The Court does not license or certify any lawyer as an expert or specialist on any particular field of practice. d'Oliveira & Associates, P.C. is not a partnership but a professional corporation, where Attorney Paul d'Oliveira is the sole shareholder. Except for auto accidents, slip and fall, social security disability, and wrongful death cases, most cases listed above are not handled by this firm but are referred to other attorneys, and in most instances, where we refer a case to another attorney, this firm maintains joint responsibility pursuant to the ethical rules in RI.

This website, provided by d’Oliveira & Associates, is an advertisement and offers general legal information, not legal advice. If you want legal advice you should contact an attorney directly. d’Oliveira & Associates does not endorse any of the content on any of the linked websites. CLICK HERE for terms of use of this website and our privacy policy. d'Oliveira & Associates reserves the rights to change the terms and conditions and/or privacy statement from time to time. If you have any questions about the Terms and Use, Privacy Policy, the practices of this website, or would like to provide comments, please contact us by phone, fax, mail or email.
d'Oliveira & Associates, P.C.2540 Pawtucket Avenue. E. Providence, RI 02914. 1-800-992-6878.